Christopher L. Jordan
General Counsel at CHIMERIX, INC.
Christopher L. Jordan active positions
| Companies | Position | Start | End |
|---|---|---|---|
| CHIMERIX, INC. | General Counsel | 07/08/2022 | - |
Career history of Christopher L. Jordan
Former positions of Christopher L. Jordan
| Companies | Position | Start | End |
|---|---|---|---|
| ENDOCYTE, INC. | General Counsel | - | - |
| ELI LILLY AND COMPANY | Corporate Officer/Principal | - | - |
| NOVARTIS AG | General Counsel | - | - |
Training of Christopher L. Jordan
| George Washington University | Graduate Degree |
| Purdue University | Undergraduate Degree |
Statistics
International
| United States | 6 |
| Switzerland | 2 |
Operational
| General Counsel | 3 |
| Graduate Degree | 1 |
| Undergraduate Degree | 1 |
Sectoral
| Health Technology | 5 |
| Consumer Services | 3 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 3 |
|---|---|
| CHIMERIX, INC. | Health Technology |
| NOVARTIS AG | Health Technology |
| ELI LILLY AND COMPANY | Health Technology |
| Private companies | 1 |
|---|---|
Endocyte, Inc.
 Endocyte, Inc. Pharmaceuticals: MajorHealth Technology Endocyte, Inc. engages in the development of targeted therapies for the treatment of cancer and inflammatory diseases. It uses a proprietary technology to create novel small molecule drug conjugates and companion imaging diagnostics for personalized targeted therapies. Its small molecule drug conjugates are actively target receptors that are over-expressed on diseased cells. The company was founded by P. Ron Ellis and Philip S. Low on December 6, 1995 and is headquartered in West Lafayette, IN. | Health Technology |
